chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of fever in a 50-year-old female patient who received SHINGRIX. In April 2018, the patient received SHINGRIX. In April 2018, less than a day after receiving SHINGRIX, the patient experienced fever, headache, generalized muscle aches, tiredness, dizziness and nausea. On an unknown date, the patient experienced difficulty breathing, pain in hand, nail injury, walking difficulty and nail bed bleeding. The patient was treated with dexamethasone. On an unknown date, the outcome of the fever, headache, generalized muscle aches, difficulty breathing, tiredness, dizziness, pain in hand, nail injury, nausea and walking difficulty and nail bed bleeding. The patient was treated with dexamethasone. On an unknown date, the outcome of the fever, headache, generalized muscle aches, difficulty breathing, tiredness, dizziness, pain in hand, nail injury, nausea and walking difficulty were not recovered/not resolved and the outcome of the nail bed bleeding was recovered/resolved. It was unknown if the reporter considered the fever, headache, generalized muscle aches, difficulty breathing, tiredness, dizziness, pain in hand, nail injury, nausea, walking difficulty and nail bed bleeding to be related to SHINGRIX. Additional details were provided as follows: The patient could speak another language. The patient did not get any other vaccine. The patient had the SHINGRIX vaccine about 3 weeks before the date of reporting. The first day patient had the vaccine, the patient experienced fever, nausea, tired, dizzy, headache and pain all over her muscles. The patient went out of counttry. When the patient was at the airport and it was difficult to walk well, her feet were dragging, she almost fell down because it was hard to walk and painful to move her hands. She went to have a massage the day before flying for an hour and a half and that helped a little bit. The patient also said that it was difficult for her to breath. She hurt her toenail yesterday because it was hard to walk. She was even bleeding from her toenail. The patient made a comment that she had never missed work in 15 years. The patient had perfect attendance. However, she missed work twice the week she had the vaccine. The patient said that out of the country she had a shot of dexamethasone and it helped her. However, the patient said that she was still not feeling well due to symptoms reported till the time of reporting. The patient said that she did not have the physician's information with her at the time of the call.
4/8 negative rapid covid screen for work.  4/9 845 received shot, 1200pm begain with moderate dry hacking cough, injection site pain, muscle aches.  4/10 symptoms more severe.  4/11 rapid covid test negative, worked as a hospice nurse.  4/12 coughing more severe, telehealth visit with PCP, nebulizer treatments xopenex and budesonide ordered.  4/13 symptoms unchanged.  4/14 attempted to go back to work rapid covid test positive.  PCR nasal swab performed at pharmacy.  4/17 results from PCR come back positive for Covid 19.  4/18 hospitalized with COVID pneumonia.  Discharged from Hospital 4/25
Expired dose of MMR-II that was administered to a patient / that vaccine was 10 days post expiry; The patient has not experienced anyside effects; This non-valid spontaneous report was received from a certified medical assistant referring to an unspecified patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication.  On an unknown date, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (dose, route of administration, anatomical location, lot number and expiration date were not reported) reconstituted with sterile diluent (lot number and expiration date were not provided). The medical assistant reported that vaccine was 10 days post expiry and that the patient had not experienced any side effects.  This is a non-valid case due tothe lack of patient's identifiers.
Break out in blisters on rear-end. Increased in urination. Cold symptoms. (Called provider or treatment *only change to routine may be related unsure 11/13/17). Traveled around 9/28/17 and noticed reactions then.
No adverse effects reported; Multiple patients were vaccinated with improperly stored VAQTA; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medications, were not reported.  On 11-JUN-2019, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided), lot # R018935, expiration date 05-SEP-2019, for prophylaxis (dose, route, anatomical site and frequency were not reported). The reporter stated that the vaccine had a temperature excursion of 34.2 F for 4 hours and 54 minutes, which was detected by a data logger. The vaccine had no previous temperature excursion and there were no adverse effects reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-1907USA001174: US-009507513-1907USA004852: US-009507513-1907USA004853: US-009507513-1907USA004854: US-009507513-1907USA004855: US-009507513-1907USA004856: US-009507513-1907USA004857: US-009507513-1907USA004858: US-009507513-1907USA004859: US-009507513-1907USA004860: US-009507513-1907USA004861: US-009507513-1907USA004862: US-009507513-1907USA004863: US-009507513-1907USA004864: US-009507513-1907USA004865: US-009507513-1907USA004866: US-009507513-1907USA004867: US-009507513-1907USA004868: US-009507513-1907USA004870: US-009507513-1907USA004871: US-009507513-1907USA004872: US-009507513-1907USA004873: US-009507513-1907USA004874: US-009507513-1907USA004875: US-009507513-1907USA004876: US-009507513-1907USA004877: US-009507513-1907USA004878: US-009507513-1907USA004879: US-009507513-1907USA004880: US-009507513-1907USA004881: US-009507513-1907USA004882: US-009507513-1907USA004883: US-009507513-1907USA004884: US-009507513-1907USA004885: US-009507513-1907USA004886: US-009507513-1907USA004887: US-009507513-1907USA004888: US-009507513-1907USA004889: US-009507513-1907USA004890:
fever, chills, headache, muscle aches, fatigue, sweating, joint pain lasted about 30 hours started around 6-8 hours after injection. No residual effects. As soon as 30 hours all symptoms resolved almost instantly. The fever, chills, and sweating only remained for about 20 hours.
I am diagnosed with Gillian Barr Syndrome after 2 weeks of extreme pain in my hand,legs and feet. This is a rare Auto Immune Disease that was brought on after the second dose of the Pfizer vaccine.
08/30/22 presents to ED for "generalized weakness and cough x1 week". PMHx of "atrial flutter on Coumadin, hyperlipidemia, hypertension, and asthma"
Information has been received from a Nurse Practitioner concerning a 22 year old female who on 14-MAR-2008 was vaccinated by injection with a first dose of Gardasil (lot # not reported) and fainted 15 minutes later.  No product quality complaint was involved.  The patient sought unspecified medical attention.  Additional information has been requested.
Information has been received from a 31 year old female with a penicillin allergy who on 28AUG2003 was vaccinated in the left upper arm with a second dose of varicella virus vaccine live. There was no concomitant medication. Subsequently, the patient experienced a low grade fever of 99 degrees Fahrenheit. She had some numbness in left arm for three days and a small bump at the injection site for three days. At the time of the report, the patient did not have soreness or any bump at the site. The reporter also noted that she may be pregnant but could not confirm that she was pregnant thus far. She also indicated that she had not notified her physician. The patient did not seek medical attention, no diagnostic studies were performed, and no prescription drug was required. The patient subsequently recovered. A product quality complaint was not involved. Additional information has been requested.
Bled every two weeks starting  in January. Full periods and it began to lessen, but it?s still every two weeks or so. Also, complete and total flare up of eczema, on my face, my scalp, my hands, elbows, feet, ankles. My skin peels off of my finders, toes, arms, and ankles.  I also have gotten sporadic intense pains in my hands and feet and it will result in bruising at my joints.
Pain in left arm, followed by torso tremors in the night that originated in left arm and spread to full torso.  Tremors seem to have abated in the morning.
an expired ACTHIB was administered to a patient with no reported adverse event; Initial information received on 16-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient for whom an expired haemophilus type B (HIB) (PRP/T) vaccine [ACT-HIB] was administered with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 16-Aug-2023, the patient received an expired total dose of suspect haemophilus type B (HIB) (PRP/T) vaccine Powder and solvent for solution for injection (lot UJ787AAA, expiry date- 11-AUG-2023) via unknown route in unknown administration site for Immunization with no reported adverse event (expired product administered) (latency- same day).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Shivering  (12:30 AM to 1:30 AM, 11-1/2019),    headache 12:30 AM 11/1/2019 through 11/3/2019,      tiredness 11/1/2019 to 11/2/2019,  diarrhea (11/1/2019),  muscle and joint pain  (mild, 11/1/2019 to 11/3/2019)
Parent came in and reported fever, body aches, chest tightness, headache, and fatigue.  No localized redness/swelling at injection site.
Pain swelling redness right away. About 5 days later half dollar sized red swollen spot around injection site. Slightly itchy.
Pt began feeling poorly, low energy after 24 hours.   Increasingly short of breath, not really communicating clearly, enough that I (her daughter recommended that the Dr come.   He sent for the paramedics due to low oxygen and something not being quite right.  AT hospital multiple tests were run and bacterial pulmonary pneumonia along with heart failure exacerbation was diagnosis.  She had been in her room for 2 weeks prior, with no contact with the outside world.
screaming, high pitched for hrs, advised APAP, cool compress, tried to console; 3 hrs later mom called to say pt was doing much better;
Patient received a Moderna booster from a vial punctured for over 20 times. Talked to the patient today to monitor any side effects.
lymph nodes under the right cheek were inflamed and swollen; lymph nodes under the right cheek were inflamed and swollen; sore arm; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in arm Left on 21Feb2021 (Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had the shot on the left arm. On 22Feb2021, the next day after the vaccination, patient woke up with a sore arm. On 25Feb2021, patient's lymph nodes under the right cheek were inflamed and swollen, the right side below his jaw area was swollen. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
WITHIN HOURS AFTER RECEIVING VACCINE, PATIENT DEVELOPED POSTERIOR NECK PAIN, HEADACHE, NAUSEA, AND SINCE HAS BEEN DIZZY AND LIGHTHEADED (2 DAYS POST VACCINATION).
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. On an unknown dates those patients were vaccinated with a dose of GARDASIL (lot# reported as: 0629AE, expiry date: 16-DEC-2014, dose, units, route of administration, anatomical location were not reported). The reporter stated that the expiration date on the GARDASIL was really confusing shown as 16-DEC-14. The pharmacist stated that none of the vaccine was administered to any patient, however, 3 of his staff looked at the vial and one verbalized a different response. The reporter stated this lead to product confusion. The pharmacist recommended using a four digit year such as 2014. Additional information has been requested.
hot flashes, lightheaded & unsteady, unsatisfying itching on arms & face, rash on left arm & left neck. Took Benadryl at 2:45pm which helped with the rash & itching. Felt a lot better by 4:00pm. I work in a hospital so was helped by my coworkers that were nurses, so I did not have to go to the Drs office. But if I was home and not at work, I would've gone to urgent care.
Rash on face, arms, chest and back started 5/24/05. Serious pruritus.
Pain , soreness, swollen lymph nodes, right shoulder, neck and under arm/breast.  Took excedrin, tylenol and ibuprophen for several days.
This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles and pain were unknown. It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine. Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got shingles on his/her back, very painful.  The patient was due for 2nd shot of shingles vaccine.
STOMACH HURTS; BODY ACHES; HIVES ON BOTH LEGS; BRUISE ON LEFT WRIST; This spontaneous report received from a patient concerned a 66 year old female. The patient's weight was 107 pounds, and height was 61 inches. The patient's past medical history included cyst on pancreas, and concurrent conditions included severe asthma, high blood pressure, non alcoholic, and smoker, and other pre-existing medical conditions included the patient had no known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207421A, and batch number: 207421A expiry: UNKNOWN) dose was not reported, administered on 30-APR-2021 for prophylactic vaccination. Concomitant medications included fluticasone propionate for drug used for unknown indication, omeprazole for drug used for unknown indication, ibuprofen for pain, budesonide/formoterol fumarate for severe asthma, and diltiazem. On 02-MAY-2021, the subject experienced bruise on left wrist. On 03-MAY-2021, the subject experienced hives on both legs. On 04-MAY-2021, the subject experienced stomach hurts. On 04-MAY-2021, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hives on both legs, bruise on left wrist, stomach hurts, and body aches. This report was non-serious.
Developed hives on left side of neck approximately 3 to 4 hours after receiving shot  , took Benadryl,  hives disappeared after 1 hour of taking medicine.
This case was reported by a healthcare professional (nurse) and described the occurrence of arm soreness at injection site in a 8-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 29 November 2012 at 17:00 the subject received 1st dose of FLULAVAL (.5 ml, unknown route, right deltoid) and experienced inappropriate age at vaccine administration. The subject was younger than the indicated age for FLULAVAL. In 2012, less than one week after vaccination with FLULAVAL, the subject experienced arm soreness at injection site. At the time of reporting the outcome of the event was unspecified.
Patient came into pharmacy on 12/20/2021 stating he went to a clinic/ER due to heart pain after getting a Pfizer COVID-19 shot. He stated they did an EKG and told the results inconclusive.
pt brought to ED via EMS with lethargy, chills, and poor oral intake by several days; (recently admitted to hospital with seizures; dc'd to home); prior to arrival to ED pt had a seizure (witnessed); CT brain/head did not show evidence of acute hemorrhage, mass or mid-line shift; found to be positive for COVID; dexamethasone; severe AKI and medications adjusted; experienced bradycardia to PEA arrest; CPR and medications given per ACLS protocol; pt unable to be revived
On 9/3/09 in the evening face and ears began to itch, overnight the itching got worse. Nothing seen. Pt takes CLARITIN for seasonal allergies, so took some for the itching. Which improved. It was better by Sept. 5, 2009.
hardness at injection site; injection site is warm to touch; swelling; Initial information received on 27-Jul-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves a 5 years old and unknown gender patient who had hardness at injection site, injection site is warm to touch and swelling after receiving vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL].  The patient's past medical history, medical treatment(s),concomitant medication,  vaccination(s) and family history were not provided.    On an unknown date, the patient received an unknown dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE, suspension for injection (strength, lot number and expiry date was unknown) via unknown route in unknown administration site as prophylactic vaccination. Lot number was requested.  On an unknown date the patient developed a non-serious event of hardness at injection site (infusion site induration),injection site is warm to touch (injection site warmth) and swelling (latency: unknown ) following the administration of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE.   Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the events (hardness at injection site, injection site is warm to touch, swelling).  Outcome: Unknown
Pain and numbness throughout arm down to fingers months after getting the vaccine; Pain and numbness throughout arm down to fingers months after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain and numbness throughout arm down to fingers months after getting the vaccine) and HYPOAESTHESIA (Pain and numbness throughout arm down to fingers months after getting the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain and numbness throughout arm down to fingers months after getting the vaccine) and HYPOAESTHESIA (Pain and numbness throughout arm down to fingers months after getting the vaccine). At the time of the report, PAIN IN EXTREMITY (Pain and numbness throughout arm down to fingers months after getting the vaccine) and HYPOAESTHESIA (Pain and numbness throughout arm down to fingers months after getting the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
A nurse reported that a 2 month old male received Prevnar, Acel-Imune, Hib-Titer and IPV (Aventis Pasteur SA) vaccines on 8/21/00 and within 30 hours, he developed a rash characterized as red and "splotchy" that started on his face and spread to his trunk and limbs. His eyes swelled shut and he developed a fever of 102F. The infant was "very" fussy.
No additional AE details; HBP in charge of vaccine storage calling for TE evaluation on refrigerated products. Products were administered to multiple patients.; This spontaneous report was received from a health business professional and refers to a patient of unspecified age and gender.  The patient's pertinent medical history, concomitant therapies, drug reactions and allergies were not reported.  a temperature excursion occurred on refrigerated products, with temperature of above 46 Fahrenheit (F) degrees at 62.8 F for 8 hours. On 06-SEP-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, with lot #1879864, expiration date: 19-OCT-2023, administered orally for prophylaxis (strength dose, and vaccine scheme frequency were not provided) (Product storage error). There were no previous temperature excursions. No adverse events were reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2209USA003021:02242077 US-009507513-2209USA003055:02242082 US-009507513-2209USA002510:02242136 US-009507513-2209USA002557:02242137 US-009507513-2209USA002540:02242138 US-009507513-2209USA002566:02242139 US-009507513-2209USA002779:02242131 US-009507513-2209USA002481:02242135 US-009507513-2209USA002570:02242096 US-009507513-2209USA002469:02242101 US-009507513-2209USA002559:02242113 US-009507513-2209USA002573:02242103 US-009507513-2209USA002606:02242106 US-009507513-2209USA002532:02242109 US-009507513-2209USA002746:02242132 US-009507513-2209USA002745:02242092 US-009507513-2209USA002574:02242099
PROQUAD was inadvertently administered with VARIVAX; No additional Adverse Event (AE) details; PROQUAD was inadvertently administered with VARIVAX instead of MMR-II; This spontaneous report was received from a health professional referring to an unknown age and gender patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported.  On 18-JUL-2022, the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) subcutaneous injection, lot number W004028, expiration date: 02-AUG-2023 was inadvertently administered with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot number U016064, expiration date: 20-MAY-2023, and sterile diluent, solution for injection/infusion, lot number W000443 which was determined to be valid with expiration date: 20-APR-2024, instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection; all vaccines were administered subcutaneously for prophylaxis (strength, dose and anatomical site were not provided) (wrong product administered) (accidental overdose).  No additional adverse event (AE) information was provided (no adverse event).
Confusion, Myalgia, Fever, NauseaVomiting, ARM PAIN Narrative: STAYED HOME FROM WORK DUE TO SYMPTOMS, FEVER MYALGIA
Large nodule under skin where Hep B vaccine was administered gradually turned into a fluctuant fluid collection, ultrasound showed a seroma, did not resolve after 2.5 months, incision and drainage was required by a pediatric surgeon with drainage of frank pus and placement of a drain for 7 days, culture with gram + cocci.